STAT6 and PARP Family Members in the Development of T Cell-dependent Allergic Inflammation

다국어 초록 (Multilingual Abstract)

Allergic inflammation requires the orchestration of altered gene expression in the target tissue and in the infiltrating immune cells. The transcription factor STAT6 is critical in activating cytokine gene expression and cytokine signaling both in the immune cells and in target tissue cells including airway epithelia, keratinocytes and esophageal epithelial cells. STAT6 is activated by the cytokines IL-4 and IL-13 to mediate the pathogenesis of allergic disorders such as asthma, atopic dermatitis, food allergy and eosinophilic esophagitis (EoE). In this review, we summarize the role of STAT6 in allergic diseases, its interaction with the co-factor PARP14 and the molecular mechanisms by which STAT6 and PARP14 regulate gene transcription.

참고문헌 (Reference)

1 Zheng, T, "Transgenic expression of interleukin-13 in the skin induces a pruritic dermatitis and skin remodeling" 129 : 742-751, 2009

2 Saenz, L, "Transcriptional regulation by poly(ADP-ribose) polymerase-1during T cell activation" 9 : 171-, 2008

3 Hottiger, M. O, "Toward a unified nomenclature for mammalian ADP-ribosyltransferases" 35 : 208-219, 2010

4 Baurecht, H, "Toward a major risk factor for atopic eczema: meta-analysis of filaggrin polymorphism data" 120 : 1406-1412, 2007

5 Kemeny, D. M, "The role of the T follicular helper cells in allergic disease" 9 : 386-389, 2012

6 Tomkinson, A, "The failure of STAT6-deficient mice to develop airway eosinophilia and airway hyperresponsiveness is overcome by interleukin-5" 160 : 1283-1291, 1999

7 Galli, S. J, "The development of allergic inflammation" 454 : 445-454, 2008

8 Wurster, A. L, "The biology of Stat4 and Stat6" 19 : 2577-2584, 2000

9 Bettelli, E, "Th17 : the third member of the effector T cell trilogy" 19 : 652-657, 2007

10 Brandt, E. B, "Targeting IL-4 / IL-13 signaling to alleviate oral allergen -induced diarrhea" 123 : 53-58, 2009

11 Alcorn, J. F, "TH17 cells in asthma and COPD" 72 : 495-516, 2010

12 Kweon, M, "Systemically derived large intestinal CD4 + Th2cells play a central role in STAT6-mediated allergic diarrhea" 106 : 199-206, 2000

13 Levy, D. E, "Stats: transcriptional control and biological impact" 3 : 651-662, 2002

14 Ouyang, W, "Stat6-independent GATA-3 autoactivation directs IL-4-independent Th2 development and commitment" 12 : 27-37, 2000

15 Kaplan, M. H, "Stat6 is required for mediating responses to IL-4 and for the development of Th2 cells" 4 : 313-319, 1996

16 Hebenstreit, D, "Signaling mechanisms , interaction partners , and target genes of STAT6" 17 : 173-188, 2006

17 Kuperman, D, "Signal transducer and activator of transcription factor 6 (Stat6)-deficient mice are protected from antigen-induced airway hyperresponsiveness and mucus production" 187 : 939-948, 1998

18 Goenka, S, "Selective potentiation of Stat-dependent gene expression by collaborator of Stat6(CoaSt6), a transcriptional cofactor" 103 : 4210-4215, 2006

19 Hancock, D. B, "STAT6and LRP1 polymorphisms are associated with food allergen sensitization in Mexican children" 129 : 1673-1676, 2012

20 Hoshino, A, "STAT6-mediated signaling in Th2-dependent allergic asthma: Critical role for the development of eosinophilia, airway hyper-responsiveness and mucus hypersecretion, distinct from its role in Th2 differentiation" 16 : 1497-1505, 2004

21 Turner, M. J, "STAT6-mediated keratitis and blepharitis : a novel murine model of ocular atopic dermatitis" 55 : 3803-3808, 2014

22 Crotty, S, "Review T follicular helper cell differentiation , function , and roles in disease" 41 : 529-542, 2014

23 Mikita, T, "Requirements for interleukin-4-induced gene expression and functional characterization of Stat6" 16 : 5811-5820, 1996

24 Rivas, M. N, "Regulatory T cell reprogramming toward a Th2-cell- like lineage impairs oral tolerance and promotes regulatory T cell reprogramming toward a Th2-cell-like lineage impairs oral tolerance and promotes food allergy" 42 : 512-523, 2015

25 Olabisi, O. A, "Regulation of transcription factor NFAT by ADPribosylation" 28 : 2860-2871, 2008

26 Naura, A. S, "Post-allergen challenge inhibition of poly(ADP-ribose) polymerase harbors therapeutic potential for treatment of allergic airway inflammation" 38 : 839-846, 2008

27 Amoli, M, "Polymorphism in the Stat6 gene encodes risk for nut allergy" 3 : 220-224, 2002

28 Mehrotra, P, "Poly-ADP-ribosyl polymerase-14 promotes T helper 17 and follicular T helper development" 146 : 537-546, 2015

29 Schreiber, V, "Poly(ADP-ribose): novel functions for an old molecule" 7 : 517-528, 2006

30 Oumouna, M, "Poly(ADP-ribose) polymerase-1 inhibition prevents eosinophil recruitment by modulating Th2 cytokines in a murine model of allergic airway inflammation: a potential specific effect on IL-5" 177 : 6489-6496, 2006

31 Kim, M. Y, "Poly (ADPribosyl)ation by PARP-1 : 'PAR-laying' NAD + into a nuclear signal" 19 : 1951-1967, 2005

32 Mehrotra, P, "Poly (ADP-ribose) polymerase 14 and its enzyme activity regulates TH2 differentiation and allergic airway disease" 131 : 521-531, 2013

33 Bai, P, "Poly (ADP-Ribose ) polymerase mediates inflammation in a mouse model of contact hypersensitivity" 129 : 234-238, 2009

34 Niranjan, R, "Pathogenesis of allergen-induced eosinophilic esophagitis is independent of interleukin (IL)-13" 91 : 408-415, 2013

35 Yélamos, J, "PARP-2 deficiency affects the survival of CD4+CD8+ doublepositive thymocytes" 25 : 4350-4360, 2006

36 Cho, S. H, "PARP-14, a member of the B aggressive lymphoma family, transduces survival signals in primary B cells" 113 : 2416-2425, 2009

37 Mehrotra, P, "PARP-14 functions as a transcriptional switch for Stat6-dependent gene activation" 286 : 1767-1776, 2011

38 Riley, J. P, "PARP-14 binds specific DNA sequences to promote Th2 cell gene expression" 8 : e83127-, 2013

39 Datta, R, "PARP-1 deficiency blocks IL-5 expression through calpaindependent degradation of STAT-6 in a murine asthma model" 66 : 853-861, 2011

40 Zhang, X, "Omeprazole blocks STAT6 binding to the eotaxin-3 promoter in eosinophilic esophagitis cells" 7 : e50037-, 2012

41 Mathias, C. B, "Mechanisms of allergy and clinical immunology IgE-mediated systemic anaphylaxis and impaired tolerance to food antigens in mice with enhanced IL-4 receptor signaling" 127 : 795-805, 2011

42 Pehrson, J.R, "MacroH2A, a core histone containing a large nonhistone region" 5075 : 1398-1400, 1992

43 Kim, B. E, "Loricrin and involucrin expression is downregulated by Th2 cytokines through STAT-6" 126 : 332-337, 2008

44 Shimoda, K, "Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene" 380 : 630-633, 1996

45 Mishra, A, "Intratracheal IL-13induces eosinophilic esophagitis by an IL-5, eotaxin-1, and STAT6-dependent mechanism" 125 : 1419-1427, 2003

46 Kagami, S, "Interleukin-4 and interleukin-13 enhance CCL26 production in a human keratinocyte cell line, HaCaT cells" 141 : 459-466, 2005

47 Webb, D. C, "Integrated signals between IL-13, IL-4, and IL-5 regulate airways hyperreactivity" 165 : 108-113, 2000

48 McCusker, C. T, "Inhibition of experimental allergic airways disease by local application of a cell-penetrating dominant-negative STAT-6 peptide" 179 : 2556-2564, 2007

49 Suzuki, Y, "Inhibition of Poly (ADP-Ribose)polymerase prevents allergen- induced asthma-like reaction in sensitized guinea pigs" 311 : 1241-1248, 2004

50 Chen, C, "Induction of interleukin-9-producing mucosal mast cells promotes susceptibility to IgE-mediated article induction of interleukin-9-producing mucosal mast cells promotes susceptibility to IgEmediated experimental food allergy" 43 : 1-15, 2015

51 Nasta, F, "Increased Foxp3+ regulatory T cells in poly (ADPribose)polymerase -1 deficiency" 184 : 3470-3477, 2010

52 Ladurner, A. G, "Inactivating chromosomes: A macro domain that minimizes transcription" 12 : 1-4, 2003

53 Forbes, E. E, "IL-9 - and mast cell -mediated intestinal permeability predisposes to oral antigen hypersensitivity" 205 : 897-913, 2008

54 Sehra, S, "IL-4regulates skin homeostasis and the predisposition toward allergic skin inflammation" 184 : 3186-3190, 2010

55 Sehra, S, "IL-4 is a critical determinant in the generation of allergic inflammation initiated by a constitutively active Stat6" 180 : 3551-3559, 2008

56 Brunyanszki, A, "Genetic ablation of PARP-1 protects against oxazolone-induced contact hypersensitivity by modulating oxidative stress" 130 : 2629-2637, 2010

57 Boulares, A. H, "Gene knockout or pharmacological inhibition of poly(ADP-ribose) polymerase-1prevents lung inflammation in a murine model of asthma" 28 : 322-329, 2003

58 Vyas, S, "Family-wide analysis of poly(ADPribose)polymerase activity" 5 : 4426-, 2014

59 Chan, L. S, "Expression of interleukin-4 in the epidermis of transgenic mice results in a pruritic inflammatory skin disease: an experimental animal model to study atopic dermatitis" 117 : 977-983, 2001

60 Bruns, H. A, "Expression of a constitutively active Stat6 in vivo alters lymphocyte homeostasis with distinct effects in T and B cells" 170 : 3478-3487, 2003

61 Takeda, K, "Essential role of Stat6 in IL-4 signalling" 380 : 627-630, 1996

62 Blanchard, C, "Eotaxin-3/CCL26 gene expression in intestinal epithelial cells is up-regulated by interleukin-4and interleukin-13 via the signal transducer and activator of transcription 6" 37 : 2559-2573, 2005

63 Blanchard, C, "Eotaxin-3 and a uniquely conserved gene expression profile in eosinophilic esophagitis" 116 : 536-547, 2006

64 Furuta, G. T, "Eosinophilic Esophagitis" 373 : 1640-1648, 2015

65 Virág, L, "Effects of poly(ADP-ribose) polymerase inhibition on inflammatory cell migration in a murine model of asthma" 10 : R77-R83, 2004

66 Kuperman, D. A, "Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma" 8 : 885-889, 2002

67 Burton, O. T, "Direct effects of IL-4 on mast cells drive their intestinal expansion and increase susceptibility to anaphylaxis in a murine model of food allergy" 6 : 740-750, 2013

68 Hamid, Q, "Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis" 94 : 870-876, 1994

69 Sherrill, J. D, "Desmoglein-1 regulates esophageal epithelial barrier function and immune responses in eosinophilic esophagitis" 7 : 718-729, 2014

70 Howell, M. D, "Cytokine modulation of atopic dermatitis filaggrin skin expression" 120 : 150-155, 2007

71 Nomura, I, "Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes" 171 : 3262-3269, 2003

72 Gupta, S. K, "Cytokine expression in normal and inflamed esophageal mucosa: a study into the pathogenesis of allergic eosinophilic esophagitis" 42 : 22-26, 2006

73 Krishnamurthy, P, "Correlation of increased PARP14 and CCL26 expression in biopsies from children with eosinophilic esophagitis" 133 : 577-580, 2014

74 Blanchard, C, "Coordinate interaction between IL-13 and epithelial differentiation cluster genes in eosinophilic esophagitis" 184 : 4033-4041, 2010

75 Palmer, C. N. A, "Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis" 38 : 441-446, 2006

76 Goenka, S, "Collaborator of Stat6 (CoaSt6)-associated poly(ADP-ribose) polymerase activity modulates Stat6-dependent gene transcription" 282 : 18732-18739, 2007

77 Quelle, F. W, "Cloning of murine Stat6 and human Stat6, Stat proteins that are tyrosine phosphorylated in responses to IL-4 and IL-3 but are not required for mitogenesis" 15 : 3336-3343, 1995

78 Rosado, M. M, "Beyond DNA repair, the immunological role of PARP-1 and its siblings" 139 : 428-437, 2013

79 Elias, J. A, "Airway remodeling in asthma" 104 : 1001-1006, 1999

80 Sicherer, S. H, "Advances in allergic skin disease, anaphylaxis, and hypersensitivity reactions to foods, drugs, and insects in 2014" 135 : 357-367, 2014

81 Hoeck, J, "Activation of eotaxin-3/CCLl26 gene expression in human dermal fibroblasts is mediated by STAT6" 167 : 3216-3222, 2001

82 Akimoto, T., "Abrogation of bronchial eosinophilic inflammation and airway hyperreactivity in signal transducers and activators of transcription (STAT)6-deficient mice" 187 : 1537-1542, 1998

83 Chiba, Y, "A novel STAT6 inhibitor AS1517499ameliorates antigen-induced bronchial hypercontractility in mice" 41 : 516-524, 2009